Increasing testosterone levels and effects on cognitive functions in elderly men and women: A review

Current Drug Targets: CNS and Neurological Disorders

Volumn 4, Issue 5, 2005, Pages 531-540

  Hogervorst, E ^a,b   Bandelow, S ^b   Moffat, S D ^c  

^a Department of Human Sciences   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's; Cognition; Dementia; Estradiol; Estrogens; Memory; Testosterone

Indexed keywords

ANDROGEN; APOLIPOPROTEIN E; AROMATASE; BOLDENONE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GLUTAMINE; GONADOTROPIN; METHYLTESTOSTERONE; PLACEBO; TESTOSTERONE; TESTOSTERONE ENANTATE;

AGE; AGED; ALZHEIMER DISEASE; BRAIN DEGENERATION; CACHEXIA; CARDIOVASCULAR DISEASE; CASTRATION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DRUG MECHANISM; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; GERIATRIC PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; NEUROPROTECTION; POSTMENOPAUSE; REVIEW; RISK REDUCTION;

AGED; AGING; ANIMALS; COGNITION; COGNITION DISORDERS; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; RATS; RESEARCH SUPPORT, NON-U.S. GOV'T; TESTOSTERONE;

EID: 26844559338     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800705774322049     Document Type: Review

References (90)

1. Association, A.P. Diagnostic and Statistical manual of Mental Disorders, DSM-IV; American Psychiatric Association: Washington D.C., 1994.
2. Hebert, L.E.; Scherr, P.A.; Bienias, J.L.; Bennett, D.A.; Evans, D.A. Arch. Neurol., 2003, 60, 1119-1122.
3. Juraska, J.M. Psychoneuroendocrinology, 1991, 16, 105-109.
4. Roof, R.L.; Havens, M.D. Brain Res., 1992, 572, 310-313.
5. Kerr, J.E.; Allore, R.J.; Beck, S.G.; Handa, R.J. Endocrinology, 1995, 136, 3213-3221.
6. Braak, H.; Braak, E. J. Neural. Transmission Suppl., 1998, 127-140.
7. Pouliot, W.A.; Handa, R.J.; Beck, S.G. Synapse, 1996, 23, 10-19.
8. Morse, J.K.; DeKosky, S.T.; Scheff, S.W. Exp. Neurol., 1992, 118, 47-52.
9. Tirassa, P.; Thiblin, I.; Agren, G,; Vigneti, E.; Aloe, L.; Stenfors, C.J. Neurosci. Res., 1997, 47, 198-207.
10. Gouras, G.; Xu, H.; Gross, R.; Greenfield, J.; Hai, B.; Wang, R.; Greengard, P. Proc. Natl. Acad. Sci. USA, 2000, 97, 1202-1205.
11. Pike, C.J. Brain Res., 2001, 919, 160-165.
12. Papsozomenos, S.C. Proc. Natl. Acad. Sci. USA, 1997, 94, 6612-6617.
13. Ahlbom, E.; Prins, G.S.; Ceccatelli, S. Brain Res., 2001, 892, 255-262.
14. Hammond, J.; Le, Q; Goodyer, C.; Gelfand, M.; Trifiro, M.; LeBlanc, A. J. Neurochem., 2001, 77, 1319-1326.
15. Gillett, M.J.; Martins, R.N.; Clarnette, R.M.; Chubb, S.A.; Bruce, D.G.; Yeap, B.B. J. Alzheimers Dis., 2003, 5, 267-269.
16. Almeida, O.P.; Waterreus, A.; Spry, N.; Flicker, L.; Martins, R. N. Psychoneuroendocrinology, 2004, 29, 1071-1081.
17. Hogervorst, E., Williams, J., Budge, M., Barnetson, L., Combrinck, M., & Smith, A.D. Neuroendocrin. Lett., 2001, 22, 163-168.
18. McEwen, B.; Alves, S.; Bulloch, K.; Weiland, N. Neurology, 1997, 48, S8-15.
19. Mensah-Nyagan, A.G.; Do-Rego, J.L.; Beaujean, D.; Luu-The, V.; Pelletier, G.; Vaudry, H. Pharmacol. Rev., 1999, 51, 63-81.
20. Toran-Allerand, C.D.; Miranda, R.C.; Bentham, W.D.; Sohrabji, F.; Brown, T.J.; Hochberg, R.B.; MacLusky, N.J. Proc. Natl. Acad. Sci. USA, 1992, 89, 4668-4672.
21. Gibbs, R.B.; Gabor, R. J. Neurosci. Res., 2003, 74, 637-643.
22. Abbasi, A.; Drinka, P.; Mattson, D.; Rudman, D. J. Am. Geriatr. Soc., 1993, 41, 975-982.
23. Bowen, R.L.; Isley, J.P.; Atkinson, R.L. J. Neuroendocrinol., 2000, 12, 351-354.
24. Paoletti, A.M.; Congia, S.; Lello, S.; Tedde, D.; Orrù, M.; Pistis, M.; Pilloni, M.; Zedda, P.; Loddo, A.; Melis, G.B. Neurology, 2004, 62, 301-303.
25. Watanabe, T.; Koba, S.; Kawamura, M.; Itokawa, M.; Idei, T.; Nakagawa, Y.; Iguchi, T.; Katagiri, T. Metabolism, 2004, 53, 476-482.
26. Rasmuson, S.; Nasman, B.; Carlstrom, K.; Olsson, T. Dementia, 2002, 13, 74-79.
27. Pennanen, C.; Laakso, M.P.; Kivipelto, M.; Ramberg, J.; Soininen, H. J. Neuroendocrinol., 2004, 16, 95-98.
28. Hogervorst, E.; Bandelow, S. J. Neuroendocrinol., 2004, 16, 93-94.
29. Moffat, S.D.; Zonderman, A.B.; Metter, E.J.; Kawas, C.; Blackman, M.R.; Harman, S.M.; Resnick, S.M. Neurology, 2004, 62, 188-193.
30. Kaufman, J.M.; Vermeulen, A. In Testosterone: action, deficiency, substitution; Nieschlag, E., Behre, H.M., Eds.; Springer-Verlag: Berlin, 1998, pp. 437-471.
31. Hogervorst, E.; Mendes Ribeiro, H.; Molyneux, A.; Budge, M.; A.D, S. Arch. Neurology, 2002, 59, 787-793.
32. Hogervorst, E.; Bandelow, S.; Combrinck, M.; Smith, A.D. Exp. Gerontol., 2004, 39, 1633-1639.
33. van Osch, L.A.; Hogervorst, E.; Combrinck, M.; Smith A., D. Neurology, 2004, 62, 1967-1971.
34. Kalmijn, S.; Mehta, K.M.; Pols, H.A.P.; Hofman, A.; Drexhage, H. A.; Breteler, M.M.B. Clin. Endocrinol., 2000, 53, 733-737.
35. Faber, J.; Gam, A.; Siersbaek-Nielsen, K. Acta Endocrinol. [Copenh], 1990, 123, 535-540.
36. Tsitouras, P.D.; Bulat; T. Endocrinol. Metab. Clin. North Am., 1995, 24, 297-315.
37. Bowen, R.L.; Smith, M.A.; Harris, P.L.; Kubat, Z.; Martins, R. N.; Castellani, R.J.; Perry, G.; Atwood, C.S. J. Neurosci. Res., 2002, 70, 514-518.
38. Bowen, R.L.; Verdile, G.; Liu, T.; Parlow, A.F.; Perry, G.; Smith, M.A.; Martins, R.N.; Atwood, C.S. J. Biol. Chem., 2004, 279, 20539-20545.
39. Short, R.A.; Bowen, R.L.; O'Brien, P.C.; Graff Radford, N.R. Mayo Clin. Proc., 2001, 76, 906-909.
40. Moffat S.D.; Zonderman, A.B.; Metter, E.J.; Blackman, M.R.; Harman, S.M.; Resnick, S.M. J. Clin. Endo. Metab., 2002, 87, 5001-5007.
41. Hogervorst, E.; Lehmann,. D.J.; Warden, D.R.; McBroom, J.; Smith, A.D. Int. J. Geriatr. Psychiatry, 2002, 17, 938-940.
42. Nelson, K.; Witte, J. S. Am. J. Epidemiol., 2002, 155, 882-890.
43. Yaffe, K.; Edwards, E.R.; Lui, L.Y.; Zmuda, J.M.; Ferrell, R.E.; Cauley, J.A. Biol. Psychiatry, 2003, 54, 943-946.
44. Lehmann, D.J.; Hogervorst, E.; Warden, D.R.; Smith, A.D.; Butler, H.T.; Ragoussis, J. J. Neurol. Neurosurg. Psychiatry, 2004, 75, 163-164.
45. Beilin, J.; Ball, E.M.; Favaloro, J.M.; Zajac, J.D. J. Mol. Endocrinol., 2000, 25, 85-96.
46. Raber, J. Sci. Aging Knowledge Environ., 2004, 17, re2.
47. Iivonen, S.; Corder, E.; Lehtovirta, M.; Helisalmi, S.; Mannermaa, A.; Vepsalainen, S.; Hanninen, T.; Soininen, H.; Hiltimen, M. Neurology, 2004, 62, 1170-1176.
48. Cherrier, M.M.; Matsumoto, A.M.; Amory, J.K.; Ahmed, S.; Bremner, W.; Peskind, E. R.; Raskind, M. A.; Johnson, M.; Craft, S. Neurology, 2005, 64, 290-296.
49. Petersen, R.C.; Smith, G.E.; Waring, S.C.; Ivnik, R.J.; Tangalos, E.G.; Kokmen, E. Arch. Neurol., 1999, 56.
50. Lamberts, S.; van den Beld AW; van der Lely, A. Science, 1997, 278, 419-424.
51. Morley, J. E.; Kaiser, F.; Raum, W.J.; Perry, H.M. r.; Flood, J.F.; Jensen, J.; Silver, A.J.; Roberts, E. Proc. Natl. Acad. Sci. USA, 1997, 94, 7537-7542.
52. Barrett-Connor, E.; Goodman-Gruen, D.; Patay, B. J. Clin. Endocrinol. Metab., 1999, 84, 3681-3685.
53. Cerhan, J. R., Folsom, A.R., Mortimer, J.A., Shahar, E., Knopman, D.S., McGovern, P.G., Hays, M.A., Crum, L.D., Heiss, G. Gerontology, 1998, 44, 95-105.
54. Hogervorst, E.; Bandelow, S.; Hart, J.J.; Henderson, V.W. Int. J. Geriatr. Psychiatry, 2004, 19, 875-880.
55. Hogervorst, E.; De Jager, C.; Budge, M.; Smith, A.D. Psychoneuroendocrinology, 2004, 29, 405-421.
56. Budge, M. M.; de Jager, C.; Hogervorst, E.; Smith, A. D.; OPTIMA. JAGS, 2002, 50, 2014-2018.
57. Wu, F. C.; von Eckardstein, A. Endocr. Rev., 2003, 24, 183-217.
58. Farrag, A. K.; Khedr, E. M.; Abdel-Aleem, H.; Rageh, T. A. Dement. Geriatr. Cogn. Disord., 2002, 13, 193-198.
59. Nappi, R. E., Sinforiani, E., Mauri, M., Bono, G., Polatti, F., Nappi, G. Gynecol. Obstet. Invest., 1999, 47, 29-36.
60. Sherwin, B. B. Psychoneuroendocrinology, 1988, 13, 345-357.
61. Salminen, E. K.; Portin, R. I.; Koskinen, A.; Helenius, H.; Nurmi, M. Clin. Cancer Res., 2004, 10, 7575-7582.
62. Cherrier, M. M.; Rose, A. L.; Higano, C. J. Urol., 2003, 170, 1808-1811.
63. Moffat, S.; Hampson, E. Psychoneuroendocrinology, 1996, 21, 323-337.
64. Wolf, O. T.; Preut, R.; Hellhammer, D. H.; Kudielka, B. M.; Schurmeyer, T. H.; Kirschbaum, C. Biol. Psychiatry, 2000, 47, 650-654. .
65. Almeida, O. P. Arq. Neuropsiquiatr., 1999, 57, 701-706.
66. Sherwin, B. Exp. Gerontol., 1994, 22, 423-430.
67. Hampson, E.; Moffat, S. Brain Cogn., 1994, 26, 255-266.
68. O'Connor, D. B.; Archer, J.; Hair, W. M.; Wu, F. C. Neuropsychologia, 2001, 39, 1385-1394.
69. Slabbekoorn, D.; van Goozen, S. H.; Megens, J.; Gooren, L. J.; Cohen-Kettenis, P. T. Psychoneuroendocrinology, 1999, 24, 423-447.
70. Wolf, O. T.; Kirschbaum, C. Horm. Behav., 2002, May;41, 259-266.
71. Carlson, L.; Sherwin, B. Psychoneuroendocrinology, 1998, 23, 583-603.
72. Drake, E. B.; Henderson, V. W.; Stanczyk, F. Z.; McCleary, C. A.; Brown, W. S.; Smith, C. A.; Rizzo, A. A.; Murdock, G. A.; Buckwalter, J. G. Neurology, 2000, 54, 599-603.
73. Aleman, A.; de Vries, W. R.; Koppeschaar, H. P.; Osman-Dualch, M.; Verhaar, H. J.; Samson, M. M.; Bol, E.; de Haan, E. H. Exp, Aging Res., 2001, 27, 283-291.
74. Yaffe, K.; Lui, L. Y.; Zmuda, J.; Cauley, J. JAGS, 2002, 50, 707-712.
75. Resnick, S. M.; Henderson, V. W. JAMA, 2002, 288, 2170-2172.
76. Janowsky, J.; Oviatt, S.; Orwoll, E. Behav. Neurosci., 1994, 108, 325-332.
77. Janowsky, J. S.; Chavez, B. J. Cogn. Neurosci., 2000, 12, 407-414.
78. Cherrier, M. M.; Asthana, S.; Plymate, S.; Baker, L.; Matsumoto, A. M.; Peskind, E.; Raskind, M. A.; Brodkin, K.; Bremner, W.; Petrova, A.; LaTendresse, S.; Craft, S. Neurology, 2001, 57, 80-88.
79. Cherrier, M. M.; Plymate, S.; Mohan, S.; Asthana, S.; Matsumoto, A. M.; Bremner, W.; Peskind, E.; Raskind, M.; Latendresse, S.; Haley, A. P.; Craft, S. Psychoneuroendocrinology, 2004, 29, 65-82.
80. Sih, R.; Morley JE; Kaiser FE; Perry HM 3rd; Patrick P; Ross C J. Clin. Endocrinol. Metab., 1997, 82, 1661-1667.
81. Maki, P. M.; Brandt, J.; Dobs, A.; Mordecai-Strom, K.; Resnick, S.M., Budapest, Hungary, June 13-17, 2004.
82. Tan, R. S.; Pu, S. J. Aging Male, 2003, 6, 13-17.
83. Li, H. J.; Zhou, B. L.; Bai, L. L.; Liu, J. S.; Huang, Y. F. Zhonghua Nan Ke Xue,. 2003, 9, 193-196.
84. Hogervorst, E. The Short-lived effect of HRT; N.Rasgon, Ed., HRT John Wiley: NY, 2005.
85. Maki, P. M.; Resnick, S. M. Neuroimage, 2001, 14, 789-801.
86. Azad, N.; Pitale, S.; Barnes, W. E.; Friedman, N. J. Clin. Endocrinol. Metab., 2003, 88, 3064-3068,
87. Sherwin, B. Psychoneuroendocrinology, 1988, 13, 345-357.
88. Regestein, Q. R.; Friebely, J.; Shiften, J.; Schiff, I. J Womens Health Gend Based Med, 2001, 10, 671-676.
89. Wisniewski, A. B.; Nguyen, T. T.; Dobs, A. S. Horm. Res., 2002, 58, 150-155.
90. Krug, R.; Molle, M.; Dodt, C.; Fehm, H. L.; Born, J, Neuropsychopharmacology, 2003; 28, 1538-1545.